In 1937 the Committee on Medicolegal Blood Grouping Tests of the American Medical Association prepared a report concerning the status at that time of the use of blood grouping in forensic medicine.1 In the intervening 15 years there have been extensive advances in the blood grouping field, stimulated primarily by the discovery of the Rh factor shortly after the report was published. In addition, the attitude of courts toward the blood tests has changed in that they are now more receptive to such evidence. Therefore, under the auspices of the Committee on Medicolegal Problems a new report, prepared in order to bring the subject up-to-date, is presented in this issue of The Journal for the information of physicians and for the guidance of attorneys confronted with such problems.
The most important advance has to do with the developments in the Rh-Hr field. With the antiserums available at the present
MEDICOLEGAL APPLICATION OF BLOOD GROUPING TESTS. JAMA. 1952;149(7):666. doi:10.1001/jama.1952.02930240044017
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: